Collaborating for effective genomic surveillance of SARS-CoV-2 variants

Variant panel discussion-YT thumbnail.2


Get a behind-the-scenes look at how Dr. Richard Michelmore, Director of the Genome Center at UC Davis, set up a PCR-based testing workflow for SARS-CoV-2 in 6 weeks and is now leading an exemplary genomic surveillance programme for emerging variants of concern. This panel discussion reveals lessons learned on the essential feedback loop with LGC, Biosearch Technologies to ensure variant detection panels remain accurate.



Dr. Richard Michelmore

Director, Genome Center
UC Davis


Dr. Tania Nolan

Head of Assay Design and Development LGC, Biosearch Technologies


Dr. Lutz Froenicke

Manager DNA Technologies Core - Genome Center
UC Davis


Dr. Lindy McClelland

Senior Scientist, Assay Design and Development Team
LGC, Biosearch Technologies

Watch now

Fill out this simple form and
get immediate access: